These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37835609)

  • 1. Hymenoptera Venom Immunotherapy in Dogs: Safety and Clinical Efficacy.
    Rostaher A; Fischer NM; Vigani A; Steblaj B; Martini F; Brem S; Favrot C; Kosnik M
    Animals (Basel); 2023 Sep; 13(19):. PubMed ID: 37835609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).
    Ruëff F; Bauer A; Becker S; Brehler R; Brockow K; Chaker AM; Darsow U; Fischer J; Fuchs T; Gerstlauer M; Gernert S; Hamelmann E; Hötzenecker W; Klimek L; Lange L; Merk H; Mülleneisen NK; Neustädter I; Pfützner W; Sieber W; Sitter H; Skudlik C; Treudler R; Wedi B; Wöhrl S; Worm M; Jakob T
    Allergol Select; 2023; 7():154-190. PubMed ID: 37854067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity.
    Moore A; Burrows AK; Rosenkrantz WS; Ghubash RM; Hosgood G
    Vet Dermatol; 2023 Dec; 34(6):532-542. PubMed ID: 37395162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.
    Hockenhull J; Elremeli M; Cherry MG; Mahon J; Lai M; Darroch J; Oyee J; Boland A; Dickson R; Dundar Y; Boyle R
    Health Technol Assess; 2012; 16(12):III-IV, 1-110. PubMed ID: 22409877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients.
    Pospischil IM; Kagerer M; Cozzio A; Angelova-Fischer I; Guenova E; Ballmer-Weber B; Hoetzenecker W
    Int Arch Allergy Immunol; 2020; 181(10):783-789. PubMed ID: 32781451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venom allergen immunotherapy.
    Golden DBK
    Allergy Asthma Proc; 2022 Jul; 43(4):339-343. PubMed ID: 35818146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of a Hymenoptera serological immunoglobulin (Ig)E assay for the diagnosis of venom hypersensitivity in dogs.
    Chan HH; Burrows AK; Hosgood G; Ghubash R
    Vet Dermatol; 2023 Dec; 34(6):543-553. PubMed ID: 37485613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D; Bircher AJ; Scherer K
    J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse reactions in venom immunotherapy protocols: conventional versus ultra-rush.
    Selcuk A; Baysan A; Yesillik S; Demirel F; Kartal O; Gulec M; Musabak U; Sener O
    Ann Med; 2022 Dec; 54(1):2321-2325. PubMed ID: 36111408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
    Fricker M; Helbling A; Schwartz L; Müller U
    J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venom immunotherapy: clinical efficacy, safety and contraindications.
    Kosnik M; Korosec P
    Expert Rev Clin Immunol; 2015; 11(8):877-84. PubMed ID: 26018865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of rush immunotherapy in patients with Hymenoptera allergy in Japan.
    Hirata H; Asakura T; Arima M; Cheng G; Honda K; Fukushima F; Yamaguchi B; Yoshida N; Fukuda T
    Asian Pac J Allergy Immunol; 2003 Jun; 21(2):89-94. PubMed ID: 14629126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F; Wenderoth A; Przybilla B
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hymenoptera venom allergy in outdoor workers: Occupational exposure, clinical features and effects of allergen immunotherapy.
    Toletone A; Voltolini S; Passalacqua G; Dini G; Bignardi D; Minale P; Massa E; Signori A; Troise C; Durando P
    Hum Vaccin Immunother; 2017 Feb; 13(2):477-483. PubMed ID: 27924689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of hymenoptera venom allergy and venom immunotherapy.
    Bilò MB; Tontini C; Martini M; Corsi A; Agolini S; Antonicelli L
    Eur Ann Allergy Clin Immunol; 2019 Nov; 51(6):244-258. PubMed ID: 31594296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.
    Bonadonna P; Zanotti R; Pagani M; Bonifacio M; Scaffidi L; Olivieri E; Franchini M; Reccardini F; Costantino MT; Roncallo C; Mauro M; Boni E; Rizzini FL; Bilò MB; Marcarelli AR; Passalacqua G
    J Allergy Clin Immunol Pract; 2018; 6(4):1368-1372. PubMed ID: 29258788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of venom immunotherapy: a real life study.
    Kołaczek A; Skorupa D; Antczak-Marczak M; Kuna P; Kupczyk M
    Postepy Dermatol Alergol; 2017 Apr; 34(2):159-167. PubMed ID: 28507496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of honeybee and wasp tyrosine-adsorbed venom immunotherapy.
    Severino M; Simioni L; Bonadonna P; Cantone R; Cortellini G; Crescioli S; D'Angelo A; La Rosa L; Macchia D; Martignago I; Massolo A; Reccardini F; Bagnasco D; Passalacqua G
    World Allergy Organ J; 2019 Dec; 12(12):100086. PubMed ID: 31768218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.